The Eradication of Carcinogenic Viruses in Established Solid Cancers

Area of Science:

• Oncology
• Virology
• Immunology

Background:

• Carcinogenic viruses (oncoviruses) can initiate cancer, but their influence on established tumors varies, affecting patient survival.
• The differential impact of oncoviruses on cancer progression necessitates a nuanced understanding of their host interactions.

Purpose of the Study:

• To classify oncoviruses based on their induced CD8+ T cell response in non-cancerous tissues.
• To determine if this classification can predict the effect of oncoviruses on solid cancer prognosis.
• To guide therapeutic strategies for oncovirus-associated cancers.

Main Methods:

• Categorization of oncoviruses based on the strength of CD8+ T cell reactions in non-cancerous tissues.
• Evaluation of the model's predictive accuracy for oncovirus impact on survival across seven known oncoviruses.
• Analysis of CD8+ T cell response persistence from benign tissues to tumors.

Main Results:

• Oncoviruses were classified into two groups: those inducing strong CD8+ T cell reactions and those inducing weak reactions.
• The classification accurately predicted the effect of six out of seven oncoviruses on survival in solid cancers.
• CD8+ T cell responses to oncoviruses appear to be maintained in tumors, mirroring responses in infected benign tissues.

Conclusions:

• Immune modulation by oncoviruses significantly influences cancer prognosis.
• Targeted eradication of oncoviruses eliciting weak CD8+ T cell responses may be beneficial in established solid tumors.
• Immunological responses to oncoviruses offer a reliable method for predicting solid cancer prognosis, even without clinical data.